Article info
PDFCommentary: Primary care
Supplementary antimicrobials for patients with HIV and <100 CD4 cells/µL are associated with improved survival
- Correspondence to Professor George W Rutherford, Department Global Health Sciences, University of California, San Francisco, CA 94143-1224, USA; George.Rutherford{at}ucsf.edu
Citation
Supplementary antimicrobials for patients with HIV and <100 CD4 cells/µL are associated with improved survival
Publication history
- Accepted October 27, 2017
- First published November 13, 2017.
Online issue publication
November 24, 2017
Article Versions
- Previous version (13 November 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.